Agendia forms research collaboration in colorectal cancer
This article was originally published in Clinica
Executive Summary
Agendia is to collaborate with the University of Texas MD Anderson Cancer Center and the Netherlands Cancer Institute (NKI) on research into improving the diagnosis and treatment of colorectal cancer.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.